17772-132 : Qelbree 150 mg Oral Capsule, Extended Release


NDC: 17772-132
Labeler: Supernus Pharmaceuticals, Inc
Product Type: Human Prescription Drug
Drug Name:  Qelbree
Dosage Form: Oral Capsule, Extended Release
Application #: NDA211964
Rev. Date: 


NDC Package Codes:

  • 17772-132-01: 100 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (17772‑132‑01)
  • 17772-132-07: 7 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (17772‑132‑07)
  • 17772-132-30: 30 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (17772‑132‑30)
  • 17772-132-60: 60 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (17772‑132‑60)
  • 17772-132-90: 90 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (17772‑132‑90)

Active Ingredients:

  • Viloxazine Hydrochloride

Dosage Strength:

  • 150 mg

Pharmaceutical Classes:

  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Cytochrome P450 2B6 Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Norepinephrine Reuptake Inhibitor [EPC]
  • Norepinephrine Uptake Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 17772-131 Qelbree 100 mg Oral Capsule, Extended Release by Supernus Pharmaceuticals, Inc
  • 17772-133 Qelbree 200 mg Oral Capsule, Extended Release by Supernus Pharmaceuticals, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 17772-132 QR Code

< Prev: 17772-131Next: 17772-133 >

Related Discussions:

Quelbree (Viloxazine) vs Strattera (Atomoxetine)
Quelbree (Viloxazine) vs Strattera (Atomoxetine) Has anyone tried both who can compare them? ## I spelled Qelbree wrong.... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.